{"id":"W4406227864","doi":"10.1080/14796694.2024.2439178","title":"Asciminib versus bosutinib following 2 or more prior therapies in chronic myeloid leukemia: a plain language summary of the ASCEMBL study","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Bosutinib; Medicine; Myeloid leukemia; Oncology; Side effect (computer science); Internal medicine; Tyrosine-kinase inhibitor; Drug; Imatinib; Pharmacology; Nilotinib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004776016,0.0003296282,0.0008890213,0.000241442,0.0001243098,0.000009324972,0.0004008441,0.0004012418,0.0001869077],"category_scores_gemma":[0.0002685714,0.0002043232,0.0002622879,0.0007973452,0.0001480132,0.00005911851,0.00025547,0.0007330067,0.0000113378],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.008016142,"about_ca_system_score_gemma":0.006951465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005202632,"about_ca_topic_score_gemma":0.00855107,"domain_scores_codex":[0.9977478,0.0003356924,0.0005708683,0.0004998791,0.0003487354,0.0004969953],"domain_scores_gemma":[0.998233,0.0006201809,0.0001970578,0.000835376,0.00004360618,0.00007080611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04924497,0.008422371,0.2517708,0.001969722,0.01120698,0.01062357,0.1368245,0.0001748746,0.03569643,0.00103695,0.04203515,0.4509937],"study_design_scores_gemma":[0.1501534,0.01092707,0.5507828,0.001394948,0.002163374,0.0001206915,0.1169752,0.0002015386,0.004838048,0.0000342291,0.161735,0.0006737412],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9797674,0.004988883,0.000001626057,0.003196771,0.002069981,0.002045688,0.00001395636,0.00006618907,0.007849479],"genre_scores_gemma":[0.9929398,0.0001689055,0.0002657842,0.0005747724,0.0005348677,0.0002177063,0.0000262773,0.00003747192,0.005234357],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.45032,"threshold_uncertainty_score":0.9986782,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01723574195103834,"score_gpt":0.3434522840867526,"score_spread":0.3262165421357143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}